Apatinib for Metastatic or Locoregionally Recurrent Nasopharyngeal Carcinoma After Failure of Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Apatinib for the Treatment of Metastatic or Locoregionally Recurrent Nasopharyngeal Carcinoma After Failure of Chemotherapy: A Multicenter, Single-Arm, Prospective Phase 2 Study
Cancer 2021 May 27;[EPub Ahead of Print], X Ruan, JH Liang, Y Pan, R Cai, RJ Zhang, Z He, X Yang, Z Niu, W JiangFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.